Tai Pang Ip

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag et autres

us, gb, de, es, dk, gr, pl (code pays fourni par la source)

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897

Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et autres

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt et autres

dk, de, gr, us, es, gb (code pays fourni par la source)

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos et autres

dk, ca, us, de, gr, es, be, au, il (code pays fourni par la source)

Semi-individualised Chinese Medicine Treatment for Diabetic Kidney Disease – From users’ perspectives to SCHEMATIC trial interim result and potential mechanisms

Kam Wa Chan, Alfred Siu Kei Kwong, Gary C.W. Chan, Crystal Pui Sha Leung et autres

hk (code pays fourni par la source)